Company: BGLC
Filing Date: 2025-12-02
Form Type: 8-K
Source: 0001477932-25-008724
Chunk: 3

Company: BioNexus Gene Lab Corp
Filing Date: 2025-12-02
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01. Financial Statement and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                                                             
         10.1      Equity Purchase Agreement, dated November 28, 2025, by and between BioNexus Gene Lab Corp. and ARC Group International Ltd.                                             
         10.2      Exclusive Intellectual Property License Agreement (Southeast Asia), dated November 28, 2025, by and between BioNexus Gene Lab Corp. and Fidelion Diagnostics Pte. Ltd.  
         99.1      Press Release, dated December 1, 2025.                                                                                                                                  
         99.2      Press Release, dated December 2, 2025.                                                                                                                                  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                             

SIGNATURES